Pain Self-Management for Opioid Use Disorder
(TREETOP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on certain opioid treatments like buprenorphine, methadone, or naltrexone for more than 7 days in the past 90 days, you cannot participate.
What data supports the effectiveness of the treatment Pain Self-Management for Opioid Use Disorder?
Research shows that an online pain self-management program can improve pain in adults undergoing treatment for opioid use disorder. Additionally, integrated pain management treatments have led to significant improvements in pain, emotional distress, and medication reduction for individuals with both chronic pain and substance use disorders.12345
Is Pain Self-Management safe for humans?
How is the Pain Self-Management treatment different from other treatments for opioid use disorder?
Pain Self-Management is unique because it focuses on helping individuals manage their pain without relying solely on medications, which is important for those with opioid use disorder who are at risk of relapse. This approach may include online programs and interdisciplinary care, offering a more holistic and personalized way to address pain compared to traditional pharmaceutical methods.13101112
What is the purpose of this trial?
The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are:* Does PSM help participants manage their chronic pain more effectively?* Does PSM help participants engage in treatment for opioid use?Researchers will compare PSM to standard care to see if PSM is effective in managing chronic pain and engagement in treatment.Participants will:* Take part in the PSM program or receive standard care for 12 weeks after enrolling in the study* Complete surveys every 3 months for 9 months (total of 4 visits)Participants will receive compensation for participating in the study.There are risks associated with participating in the study, including breach of confidentiality and psychological distress caused by discussing difficult topics.
Research Team
Erin Winstanley, PhD
Principal Investigator
University of Pittsburgh
Jessica Merlin, MD, PhD, MBA
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for individuals with chronic pain who also misuse opioids or have an opioid use disorder. They should be willing to engage in a Pain Self-Management program or receive standard care and complete surveys over 9 months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take part in the Pain Self-Management (PSM) program or receive standard care for 12 weeks
Follow-up
Participants complete surveys every 3 months for 9 months to monitor engagement and pain management
Treatment Details
Interventions
- Pain Self-Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator